Appropriated funds for Office of Generic Drugs dries up

Share this article:
FDA's Office of Generic Drugs ran out of appropriated funds April 3 and a hiring freeze was imposed, halting a recently launched aggressive recruitment program aimed at boosting staff by 50% to reduce a backlog.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

DOJ closes Brilinta investigation

AstraZeneca announced the end of the investigation Tuesday.

Doctors back unique biosimilar names

A host of doctors has asked FDA Commissioner Margaret Hamburg to back a naming convention that would require biologics and biosimilars to have different names.

Roche has no rights to Sovaldi, panel rules

Despite a collaboration with original Sovaldi owner Pharmasset in 2004, a panel ruled Roche has no rights to HCV treatment Sovaldi.